Compare Enveric Biosciences Inc (ENVB) vs iShares Core High Dividend ETF (HDV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs iShares Core High Dividend ETF — how do they compare? Enveric Biosciences Inc trades at $1.37 (market cap $5.32M), while iShares Core High Dividend ETF trades at $28.35. The key difference: iShares Core High Dividend ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | HDV | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | — |
52-Week High | $17.40 | $28.09 |
52-Week Low | $1.28 | $23.64 |
Enterprise Value | $408.82K | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.38, up 4.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $8.77M for 2025, though it beat EPS estimates in all four quarters. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003, including IND-enabling studies and positive preclinical results.
Outlook hinges on clinical progress, with 75% analyst buy ratings supporting potential upside, but high financial losses and negative ROE/ROA pose significant risks. Investors face volatility from regulatory developments and funding needs, making it speculative despite positive sentiment from recent operational updates.
HDV (iShares Core High Dividend ETF) trades at $28.26, up 2.24% today, with a bullish technical signal from moving averages. The ETF focuses on large-cap value stocks with quality dividend payers, currently yielding approximately 3.0%. Recent corporate actions include a 1:5 stock split in April 2026 and scheduled dividend payments. Technical indicators show neutral oscillators but strong moving average support, with key resistance at $28.
HDV offers defensive sector exposure with lower volatility (beta 0.52) and competitive expense ratios. The ETF has delivered strong 5-year returns but faces concentration risk with 21.56% energy allocation. Current market sentiment is mixed, with some analysts favoring broader diversification alternatives. The dividend-focused strategy provides income stability but may lag during growth-oriented market cycles.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About iShares Core High Dividend ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index is comprised of qualified income paying securities that are screened for superior company quality and financial health as determined by Morningstar, Inc.'s proprietary index methodology. The fund is non-diversified.
Read more on HDV →
